Itaú technology company sees profits grow

ZDNet

The technology company belonging to Brazilian banking giant Itaú has managed to become profitable again just as it gets ready to terminate its operations. The woes continue for the PC market as a slowdown in smartphone and tablet growth hasn't boosted sales. Enterprises continue to evaluate Windows 10. For the third quarter or 2016, Itautec has reported net profit of R$2.8m ($867,000), following losses of R$3.1m ($960,000) seen in the same quarter a year ago. However, income has dropped 74,4 percent to R$1.8m ($557,000) during the period.


Technology Companies Take Stocks Lower Despite Media Rally

U.S. News

WHAT'S ON? TV: Charter Communications climbed after Bloomberg reported that Japanese conglomerate SoftBank is considering buying Charter. The report Sunday said that SoftBank initially wanted to combine Charter with Sprint, but after Charter rejected that idea, the technology company may buy Charter outright. Shares of the cable company jumped $17.96, or 4.9 percent, to $388.22, and investors value Charter at about $100 billion. A little more than a year ago Charter bought Time Warner Cable and Bright House Networks for $67 billion.


US sanctions technologies company boosting Syria WMD program

U.S. News

The spokesman for the National Security Council, Ned Price, says that the order to sanction the technologies company "is the first time the United States is sanctioning specific Syrian officials in connection with Syria's violation of the Chemical Weapons Convention."


Healthcare technology company signs SRAs with NHS Trusts - Digital Health Age

#artificialintelligence

Healthcare technology company Sensyne Health has signed Strategic Research Agreements (SRA) with Wye Valley and George Eliot Hospital NHS Trusts. The agreements will allow Sensyne Health to analyse anonymised patient data using clinical artificial intelligence (Clinical AI) technology. The purpose of the research is to derive new insights that will improve the care of NHS Trusts' patients and help to find new treatments. Both Trusts will receive a £2.5 million equity stake in Sensyne Health (at a price of £1.75 per share) and will also benefit from royalties that arise from any discoveries. The royalties the Trust receives will be reinvested back into the NHS which can fund further research and can help deliver higher quality patient care at lower cost.


Jason Chaffetz: Apple's Tim Cook is right: Americans' privacy should be treated as a fundamental right

FOX News

Calling the efforts of technology companies to collect, store, and sell our personal data "surveillance," Apple CEO Tim Cook last week called for federal regulation to protect a fundamental right to privacy. Having run multiple bills addressing this issue during my service in Congress, I wholeheartedly agree with Cook. Americans deserve better protection than we are getting – and Congress must catch up fast. The European Union led out with strict policy protections last May with the passage of the General Data Protection Regulation (GDPR), which sets a new standard for the protection of consumer data. Here in the U.S., Cook is calling for an approach utilizing four key principles.